Moreover, psoriasis-like skin proliferative and inflammatory phenotypes are significantly rescued in DKO mice in which S100A9 is also genetically deleted11, suggesting that S100A9 could be a useful therapeutic target for psoriasis. This evidence concerns the gene S100A9 and psoriasis.